Ursodiol and Osmotic demyelination syndrome - a phase IV clinical study of FDA data

Summary:

Osmotic demyelination syndrome is reported only by a few people who take Ursodiol.

The phase IV clinical study analyzes which people take Ursodiol and have Osmotic demyelination syndrome. It is created by eHealthMe based on reports of 13,551 people who have side effects while taking Ursodiol from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 18, 2023

13,551 people reported to have side effects when taking Ursodiol.
Among them, 2 people (0.01%) have Osmotic demyelination syndrome.

What is Ursodiol?

Ursodiol has active ingredients of ursodiol. It is often used in primary biliary cirrhosis. eHealthMe is studying from 13,766 Ursodiol users for its effectiveness, alternative drugs and more.

What is Osmotic demyelination syndrome?

Osmotic demyelination syndrome (increased serum sodium level leads to hyponatremic encephalopathy) is found to be associated with 236 drugs and 141 conditions by eHealthMe.

Number of Ursodiol and Osmotic demyelination syndrome reports submitted per year:

Could Ursodiol cause Osmotic demyelination syndrome?

Common drugs people take besides Ursodiol *:

Sertraline: 2 people, 100.00%
Pantoprazole: 2 people, 100.00%
Desferal: 2 people, 100.00%
Cresemba: 1 person, 50.00%

Common side effects people have besides Osmotic demyelination syndrome *:

Visual Acuity Reduced (reduced clearness of vision): 2 people, 100.00%
Optic Neuropathy (optic nerve damage): 1 person, 50.00%
Optic Neuritis (optic nerve inflammation): 1 person, 50.00%
Blindness: 1 person, 50.00%

Common conditions people have *:

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ursodiol and have Osmotic demyelination syndrome?

Check whether Osmotic demyelination syndrome is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Osmotic demyelination syndrome and when was it recovered:

Osmotic demyelination syndrome in Ursodiol

Expand to all the drugs that have ingredients of ursodiol:

Osmotic demyelination syndrome and drugs with ingredients of ursodiol

Alternative drugs to, pros and cons of Ursodiol:

Ursodiol (13,766 reports)

Common Ursodiol side effects:

Itching: 1,007 reports
Fatigue (feeling of tiredness): 918 reports
Diarrhea: 885 reports
Fever: 702 reports
Pneumonia: 609 reports
Headache (pain in head): 525 reports
Nausea and vomiting: 503 reports
Rashes (redness): 480 reports

Browse all side effects of Ursodiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Osmotic demyelination syndrome treatments and more:

Osmotic demyelination syndrome (645 reports)

COVID vaccines that are related to Osmotic demyelination syndrome:

All the drugs that are associated with Osmotic demyelination syndrome:

Osmotic demyelination syndrome (236 drugs)

All the conditions that are associated with Osmotic demyelination syndrome:

Osmotic demyelination syndrome (141 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ursodiol (the active ingredients of Ursodiol) and Ursodiol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.